Aristo Bio-Tech and Lifescience Limited (NSEI: ARISTO)
Materials · Chemicals · IN
Rs108.00
-1.19% today · -1.8% 1Y
Aristo Bio-Tech and Lifescience Limited (NSEI: ARISTO) operates in the Chemicals industry within the Materials sector. The company is valued at $7.70M.
Over the last twelve months the share price has lost 1.8%, trading between 74.30 and 140.00.
Tweenvest scores Aristo Bio-Tech and Lifescience Limited across four factors: quality 53/100, value 74/100, growth 78/100, dividend 8/100. Its strongest factor is growth.
ARISTO price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $7.70M
- Revenue (TTM)
- $38.79M
- P/E
- 10.24
- EPS
- 10.55
- Dividend yield
- 0.56%
- Beta (5Y)
- 0.54
- 52-week high
- Rs140.00
- 52-week low
- Rs74.30
- Avg volume (3M)
- —
- Shares outstanding
- 6.81M
- Employees
- —
- Next earnings
- —
Other Chemicals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Linde plcNasdaqGS: LIN | $224.76B | $485.39 | -0.45% |
| L'Air Liquide S.A.ENXTPA: AI | $124.17B | €168.20 | +0.65% |
| The Sherwin-Williams CompanyNYSE: SHW | $83.64B | $346.29 | -0.09% |
| Ecolab Inc.NYSE: ECL | $78.95B | $285.89 | +1.51% |
| Shin-Etsu Chemical Co., Ltd.TSE: 4063 | $70.78B | ¥6,051.00 | -1.79% |
| Air Products and Chemicals, Inc.NYSE: APD | $67.94B | $302.37 | -0.89% |
| Corteva, Inc.NYSE: CTVA | $54.57B | $81.46 | -0.40% |
| BASF SEXTRA: BAS | $51.93B | €52.43 | +1.47% |
Figures last refreshed Aug 18, 2026.